Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

130 neighborhood-based * networks

12th World AIDS Conference

wo north Buenos Aires
a high seroprevalence
ealth center in a poor
reach in a Los Angeles
escription medications/
cessful desensitization/
y protease genotyping/
ch Prometheus study/
nhibitor based therapy/
mary HIV infection with

- Keyword
neighborhood hospitals/Partner stu
/The impact of a pare
of Rosario, Argentina
coffee house/Taking
Nelfinavir-associated diarrhea is me
Nelfinavir-induced urticaria and suc
Nelfinavir in HAART-experienced HI, didanosine and stavudine
-nevirapine rescue therapy
nelfinavir, zidovudine, and lamuvidi

Abstract--
idies: 23159
nt trai 24297
i/HIV 33330
it to t 43125
nage 12401;cessf 60967
V-1 in 41215
Sin HI 42281
for p 60365
ne/Tr 12197

I

64: Virologic efficacy of (NFV) and/or efavirenz (EFV) in 125*/12203
psule (SQV-SGC) plus (NFV) in HIV-infected individual 290*/12222
d TID dosing Viracept ( ) in combination with stavudine ( 12224, didanosine (ddl), and combination therapy in pretreat 12226
capsules (SQV-SGC) + (NFV) + nucleoside reverse tran 12248
m effects of ritonavir and in HIV-infected children/Short-t 12251
der a triple-therapy with and two RT-inhibitors in previou 12256
ction/UK experience of in paediatric HIV-1 infection/UK 12258
rapy/Stavudine (d4T), (NFV) and nevirapine (NVP): Su 12275
(PI)/Limited efficacy of after failure of other protease inh 12281
ombination including in patients failing treatment inclu 12285
nts switching therapy to /Reversal of hyperlipidaemia an 12287
HIV disease/Combined /saquinavir protease inhibitor tre 12303
hip in Phase III study of mesylate (Viracept~)/Virologic r 12304
ected with combination,saquinavir, stavudine, and lami 12305
n with 2 nucleosides or (NFV) plus 1 nucleoside in HIV- 12314
al experience/Effect of /indinavir/delavirdine in HIV+ pat 12329
ngoing experience with substitution for indinavir or riton 12332
ion after changing from - to indinavir-containing regimen 12342
uation of MKC-442 and (NFV) in healthy male and femal 12380
)/The treatment (TX) of (NFV) induced diarrhea (NFVID 12383
center who have taken in the past twelve months/The i 12392
cacy and drug levels of plus saquinavir as salvage thera 22338
stration of indinavir and: Pharmacokinetics, tolerability, 22352
mbination therapy with,stavudine and lamivudine (HAA 22362
line triple therapy?/Are containing regimens effective as 22381
ness and tolerability of (NFV) in combination with efavir 22386
mbination therapy with /saquinavir compared to ritonavi 22391
in patients treated with in combination with AZT and 3T 22400
itching from indinavir to /Protease inhibitor-associated h 32172
nation therapy including in pregnancy/Triple combinatio 32419
h the protease inhibitor mesylate/Predictors of respons 41191
irological response to /Impact of protease gene mutati 41222
plasma correlates with concentrations in plasma/The r 510*/42259
etween ritonavir (RTV), (NFV), and the nelfinavir active 42265
c analysis of ViraceptTM ( mesylate) in HIV-infected patien 42267
ate pharmacokinetics of mesylate (NFV; Viracept~) in HI 42274
rom indinavir (IDV) to (NFV) in patients on antiviral co 60181
population/Low rate of discontinuation in a clinic popula 60273
compassionate release /Antiviral benefits of compassio 60427
rug therapy including and saquinavir as rescue therap 60480
ID dosing of ViraceptTM ( mesylate) with 2 NRTI's/Safety 60631
ood passage in Macaca nemestrina /Enhanced pathogenicity of S 11218
azole on Cryptococcus neoformans infection in MAIDS mice/Anti 11235
trains of Cryptococcus isolated from CNS Fluid of Al 31213
lation of Cryptococcus infection in MAIDS mice by Z- 60313
onses on Cryptococcus infection in MAIDS mice/Pat 60314
ssion/Viral dynamics in neonatal macaques after oral inoculation 209*/11214
role of intrapartum and zidovudine treatment in reductio 12156
mission: Maternal and zidovudine (ZDV) use in Los Ang 458*/23273
ngle-dose intrapartum/ nevirapine to reduce mother to in 23281
versus intrapartum and treatment in preventing maternal 23292
onse in juvenile but not macaques/Oral inoculation with 31129
effects, obstetrical and outcomes/An analysis of a cohor 32230
e unlinked anonymous surveys through 1996/High prev 60549

- Keyword Abstract
explaining HIV/AIDS in and the developing world/The healt 60976
STD prevention among Nepalese military/An innovative approach 43393
dification and the risk of nephrolithiasis due to indinavir/Urine aci 12328
ature/Indinavir-related is associated with environ 12399
nosis of primary central nervous system lymphoma (PCNSL) in Al 22291
h AIDS/Primary central system lymphoma with negative 22299
nfected patient/Central system infection by prototheca wi 32213
berculosis of the central system in HIV infected patient/Tu 32214
Co-infection of central system by gram negative coccob 60605
mocystis carinii-DNA by nested-PCR in bronchoalveolar lavage (B 22184
s genomes/A multiplex nested PCR assay for the detection of six c 41151
nfection by an in-house RT-PCR and measurement of the 42179
ion of JC virus DNA by polymerase chain reaction (PCR) o 60734
ected individuals in The Netherlands /HIV-1 subtypes and viruses 13195
ups in Amsterdam, The /HIV prevalence and sexual 23518
and youth clubs in The /Development, content and e 33538
en populations using of network-based sampling/Estimating char 24181
icenter study of the EC Network on HIV-Hepatitis Prevention in Pr 23527
s network: AIDS NGOS in East Africa (ANNEA) experienc 34353
erican Harm Reduction:Preventing HIV transmission am 34357
of Sheba Development (SOSDN): HIV prevention in Afric 43232
ncidence from the HIV for Prevention Trials (HIVNET) V 43543
ators in HIV education/ provides opportunity for skills sha 60261
tion (ENMP)/European Male Prostitution (ENMP)/Europ 60904
Brazilian public schools network /The state of art of AIDS preventio 13539
vention efforts/Injector embeddedness inhibits effectiven 14140
-centered clinical trials /Providing supportive care and pr 14354
e SurvUDI surveillance: 3 years of HIV surveillance amon 23172
t associated with social formation/Syringe exchange not 23195
nges in HIV psychiatric practice after 18 months of new a 24154
rug users/Targeted vs. sampling for accessing injection d 24174
n Africa/Lack of PWA in Africa/Lack of PWA 33198
ia/The total preventive program in restricting HIV-epide 33420
AIDS pandemic (MAP): Volunteerism and collegiality for 33444
documentation centres to the fight against HIV/AIDS/Co 33493
integration into a family for people affected by HIV/AIDS/ 34132
AIDS, the global e-mail on HIV/AIDS/GENDER-AIDS, th 34199
experience of a national /Working with children with HIV/A 34235
aring experience from a for women living with HIV/AIDS in 34280
Italy/Organisation of a for the assistance of HIV affected 34314
n Russia/Launching a of AIDS NGOS in Russia/Launch 34341
national/Strengthening of sexworkers from regional to int 34349
ork your body, work that - Learning the in's and out's of ne 34350
cess story of a regional of AIDS educators in the Middle E 34351
blishing an AIDS NGOs: AIDS NGOS Network in East Afri 34353
e regional AIDS training - One year of progress/The regio 34354
Amazon region/NGO's /working together to reduce HIV tr 34359
ject AIDS & Mobility: A for the support of organisations w 34360
ectives plus: A national of psychologists working in HIV a 34367
ut their health care/US of AIDS health fraud task forces e 34376
/Russian HIV/AIDS /Russian HIV/AIDS 34381
ith HIV/AIDS/Solidarity of people with HIV/AIDS/Solidarit 41199
prevention/The role of groups in Nigerian HIV/AIDS and 43167
ositives" as a protective factor/Partial herd immunity in a h 43486
an AIDS and enterprise /European AIDS and enterprise 44224
harm by HIV/AIDS care /Reduction of harm by HIV/AIDS 60102
pproach to training and building in a state with a high incid 60169
rman women and AIDS /The German women and AIDS 60708
ention and creation of a of therapists in Europe/EUROVI 60718
e intervention process/ Networking and capacity building of NGO 13494
ears PWAs experience/ among HIV positive women in 24353
for intervention/NGO - at national level and strategy 60101
ent and sexual contact networking in a cohort of pregnant women 23380
ning the in's and out's of /Work your body, work that net 34350
n Europe/International on HIV prevention and harm r 34362
DS movement through /The beginning of a people livi 34364
ions in Nigeria/Sexual and AIDS awareness program 544*/43230
hrough regional military in countries of eastern and so 359*/43391
AIDS and human rights activities: Towards the integra 44149
m indentifiers as a social tool/The use of program inde 60337
ual health interventions, and sustainability/Sexual hea 60840
g bisexuals of Calcutta/ Networks against AIDS: Organising bisex 43345
n Europe using sentinel networks of sexually transmitted diseases 13180

nce of social and family on safer sex practices based on 14177
iability in social and risk of drug users/Heterogeneity of r 23177
ysia/Social and sexual of Indonesian migrant workers i 23580
sitive, family and social for better assistance and quality 24268
Promoting sexual health through newsletters/Promoting 33510
ration/establishment of on AIDS in Nigeria/World AIDS 34169
ng environment, using and coalitions/Promoting partici 34263

r cervical intraepithelial neoplasia with serial PAP smears/Screen 22308
f cervical intraepithelial /Local HIV-1 expression in the f 22310
d cervical intraepithelial (CIN) in HIV-1+ women/Immun 32134
ected women/Cervical and condylomata in a cohort of 60980
d opportunistic infection/ syndrome after haart initiation/ 60999
CTG 219)/Mortality and neoplasms of HIV-1 infected children: Lon 12160
tis/Extensive optic disc neovascularization in a patient with cyto 22273
us students in Pokhara, Nepal /Overcoming barriers: Talking about 13525
k in nine populations in: Challenging the ideal of a woman of 206*/14227
sex worker in Pokhara, /Peer education/awareness among 183*/23508
in highway rural area of /AIDS prevention program in highwa 33117
ess to STD treatment in /Integrated reproductive health servi 83*/33237
HIV in female patients in: How much is it a problem?/STD/HI 33252
risons in Kathmandu, /Challenge in implementing HIV/AID 33586
for military personnel in /HIV/AIDS/STD education and prev 60003